Crinetics Pharmaceuticals, Inc. (CRNX)
37.48
-6.01
(-13.82%)
USD |
NASDAQ |
May 08, 16:00
36.90
-0.58
(-1.55%)
After-Hours: 20:00
Crinetics Pharmaceuticals Total Liabilities (Quarterly) : 120.68M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amneal Pharmaceuticals, Inc. | 3.500B |
| Aquestive Therapeutics, Inc. | 195.83M |
| Merck & Co., Inc. | 82.75B |
| Nektar Therapeutics | 187.06M |
| Prestige Consumer Healthcare, Inc. | 1.665B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.401B |
| Shareholders Equity (Quarterly) | 1.281B |
| Debt to Equity Ratio | 0.0374 |
| Current Ratio | 18.60 |
| Net Debt Paydown Yield | 0.02% |